Mitral Valve Replacement Best Option

Mitral valve replacement best option


at The Mount Sinai Hospital

Ruel M, Kulik A, Rubens FD et al. Late incidence and determinants of reoperation in patients with prosthetic heart valves. Eur J Cardiothorac Surg 2004;25:364–70.

Mitral valve replacement best option

doi:10.1016/j.ejcts.2003.12.013 [PubMed] [Google Scholar]

2. Johnston DR, Soltesz EG, Vakil N et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants.

What is mitral regurgitation or insufficiency?

Ann Thorac Surg 2015;99:1239–47. doi:10.1016/j.athoracsur.2014.10.070[PMC free article] [PubMed] [Google Scholar]

3. Bourguignon T, Bouquiaux-Stablo AL, Loardi C et al. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations.

A mechanical heart valve is the best choice

J Thorac Cardiovasc Surg 2014;148:2004–11.e1. doi:10.1016/j.jtcvs.2014.02.050 [PubMed] [Google Scholar]

4. Noorani A, Radia R, Bapat V. Challenges in valve-in-valve therapy.

Question on valve replacement - pig vs. mechanical

J Thorac Dis 2015;7:1501–8. doi:10.3978/j.issn.2072-1439.2015.06.16[PMC free article] [PubMed] [Google Scholar]

5. Hamm CW, Arsalan M, Mack MJ. The future of transcatheter aortic valve implantation.

Heart Valve Problems: Is Repair or Replacement Best for You?

Eur Heart J Published Online First: 17 Nov 2015. doi:10.1093/eurheartj/ehv574 [PubMed] [Google Scholar]

6. Weber A, Noureddine H, Englberger L et al.

Heart Valve Replacement Options

Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age.

J Thorac Cardiovasc Surg 2012;144:1075–83. doi:10.1016/j.jtcvs.2012.01.024 [PubMed] [Google Scholar]


Mitral valve replacement best option

Saleeb SF, Newburger JW, Geva T et al. Accelerated degeneration of a bovine pericardial bioprosthetic aortic valve in children and young adults. Circulation 2014;130:51–60. doi:10.1161/CIRCULATIONAHA.114.009835 [PubMed] [Google Scholar]

8. Nishimura RA, Otto CM, Bonow RO et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Options for Heart Valve Replacement

J Thorac Cardiovasc Surg 2014;148:e1–132. doi:10.1016/j.jtcvs.2014.05.014 [PubMed] [Google Scholar]


Mitral valve replacement best option

Vahanian A, Alfieri O, Andreotti F et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Eur J Cardiothorac Surg 2012;42:S1–44. doi:10.1093/ejcts/ezs455 [PubMed] [Google Scholar]

10. Kaneko T, Aranki S, Javed Q et al.

Mitral valve replacement best option

Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old. J Thorac Cardiovasc Surg 2014;147:117–26. doi:10.1016/j.jtcvs.2013.08.028 [PubMed] [Google Scholar]

11. Ruel M, Chan V, Bédard P et al.

Mitral valve replacement best option

Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults<60 years of age. Circulation 2007;116(11 Suppl):I294–300.

High times ipo prediction

doi:10.1161/CIRCULATIONAHA.106.681429 [PubMed] [Google Scholar]

12. Jamieson WR, von Lipinski O, Miyagishima RT et al.

Related Articles

Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after mitral valve replacement. J Thorac Cardiovasc Surg 2005;129:1301–8. doi:10.1016/j.jtcvs.2004.09.042 [PubMed] [Google Scholar]

13. Hammermeister K, Sethi GK, Henderson WG et al.

Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000;36:1152–8. doi:10.1016/S0735-1097(00)00834-2 [PubMed] [Google Scholar]

14. Surgeons SoT. STS Risk Calculator.


What Are the Treatments for Mitral Valve Regurgitation?

Kulik A, Rubens FD, Wells PS et al. Early postoperative anticoagulation after mechanical valve replacement: a systematic review. Ann Thorac Surg 2006;81:770–81.

doi:10.1016/j.athoracsur.2005.07.023 [PubMed] [Google Scholar]

16. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635–41.

doi:10.1161/01.CIR.89.2.635 [PubMed] [Google Scholar]

17. Probst P, Goldschlager N, Selzer A.


Left atrial size and atrial fibrillation in mitral stenosis. Factors influencing their relationship. Circulation 1973;48:1282–7. doi:10.1161/01.CIR.48.6.1282 [PubMed] [Google Scholar]

18. Miyata-Fukuoka Y, Izumo M, Shimada Y et al. Left atrial size and function are related to pulmonary hypertension in coronary artery disease.

How to become a cryptocurrency day trader

Echocardiography 2012;29:535–40. doi:10.1111/j.1540-8175.2011.01648.x [PubMed] [Google Scholar]

19. Hodge K, Janus E, Sundararajan V et al. Coordinated anticoagulation management in a rural setting. Aust Fam Physician 2008;37:280–3. [PubMed] [Google Scholar]

20. Manji I, Pastakia SD, Do AN et al. Performance outcomes of a pharmacist-managed anticoagulation clinic in the rural, resource-constrained setting of Eldoret, Kenya.

J Thromb Haemost 2011;9:2215–20.

Create own cryptocurrency in 10 minutes

doi:10.1111/j.1538-7836.2011.04503.x [PubMed] [Google Scholar]

21. Tajer C, Ceresetto J, Bottaro FJ et al. Assessment of the quality of chronic anticoagulation control with time in therapeutic range in atrial fibrillation patients treated with vitamin K antagonists by hemostasis specialists: the TERRA Registry: Tiempo en rango en la Republica Argentina. Clin Appl Thromb Hemost Published Online First: 5 Jan 2016. doi:10.1177/1076029615623378 [PubMed] [Google Scholar]